packageCarmustine

carmustine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Carmustine is an alkylating anticancer drug used to treat cancers such as Hodgkin disease and non-Hodgkin lymphoma. It remains an approved medicine, with an authorised product in the European Union, and carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q415869 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:carmustine
ATC codes:L01AD01
DrugBank:DB00262
PubChem CID:2578
ChEBI:3423
Wikidata:Q415869
formula:C5H9Cl2N3O2
molar mass:214.046 g/mol (PubChem CID 2578)
logP:1.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown